Cargando…

Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson’s disease

Clinical effects of anti-cholinergic drugs implicate cholinergic systems alterations in the pathophysiology of some cardinal motor impairments in Parkinson’s disease. The topography of affected cholinergic systems deficits and motor domain specificity are poorly understood. Parkinson's disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Bohnen, Nicolaas I, Kanel, Prabesh, Koeppe, Robert A, Sanchez-Catasus, Carlos A, Frey, Kirk A, Scott, Peter, Constantine, Gregory M, Albin, Roger L, Müller, Martijn L T M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196256/
https://www.ncbi.nlm.nih.gov/pubmed/34704022
http://dx.doi.org/10.1093/braincomms/fcab109
_version_ 1783706648097849344
author Bohnen, Nicolaas I
Kanel, Prabesh
Koeppe, Robert A
Sanchez-Catasus, Carlos A
Frey, Kirk A
Scott, Peter
Constantine, Gregory M
Albin, Roger L
Müller, Martijn L T M
author_facet Bohnen, Nicolaas I
Kanel, Prabesh
Koeppe, Robert A
Sanchez-Catasus, Carlos A
Frey, Kirk A
Scott, Peter
Constantine, Gregory M
Albin, Roger L
Müller, Martijn L T M
author_sort Bohnen, Nicolaas I
collection PubMed
description Clinical effects of anti-cholinergic drugs implicate cholinergic systems alterations in the pathophysiology of some cardinal motor impairments in Parkinson’s disease. The topography of affected cholinergic systems deficits and motor domain specificity are poorly understood. Parkinson's disease patients (n = 108) underwent clinical and motor assessment and vesicular acetylcholine transporter [(18)F]-fluoroethoxybenzovesamicol PET imaging. Volumes-of-interest-based analyses included detailed thalamic and cerebellar parcellations. Successful PET sampling for most of the small-sized parcellations was available in 88 patients. A data-driven approach, stepwise regression using the forward selection method, was used to identify cholinergic brain regions associating with cardinal domain-specific motor ratings. Regressions with motor domain scores for model-selected regions followed by confounder analysis for effects of age of onset, duration of motor disease and levodopa equivalent dose were performed. Among 7 model-derived regions associating with postural instability and gait difficulties domain scores three retained significance in confounder variable analysis: medial geniculate nucleus (standardized β = −0.34, t = −3.78, P = 0.0003), lateral geniculate nucleus (β = −0.32, t = −3.4, P = 0.001) and entorhinal cortex (β = −0.23, t = −2.6, P = 0.011). A sub-analysis of non-episodic postural instability and gait difficulties scores demonstrated significant effects of the medial geniculate nucleus, entorhinal cortex and globus pallidus pars interna. Among 6 tremor domain model-selected regions two regions retained significance in confounder variable analysis: cerebellar vermis section of lobule VIIIb (β = −0.22, t = −2.4, P = 0.021) and the putamen (β = −0.23, t = −2.3, P = 0.024). None of the three model-selected variables for the rigidity domain survived confounder analysis. Two out of the four model-selected regions for the distal limb bradykinesia domain survived confounder analysis: globus pallidus pars externa (β = 0.36, t = 3.9, P = 0.0097) and the paracentral lobule (β = 0.26, t = 2.5, P = 0.013). Emphasizing the utility of a systems-network conception of the pathophysiology of Parkinson's disease cardinal motor features, our results are consistent with specific deficits in basal forebrain corticopetal, peduncupontine-laterodorsal tegmental complex, and medial vestibular nucleus cholinergic pathways, against the background of nigrostriatal dopaminergic deficits, contributing significantly to postural instability, gait difficulties, tremor and distal limb bradykinesia cardinal motor features of Parkinson’s disease. Our results suggest significant and distinct consequences of degeneration of cholinergic peduncupontine-laterodorsal tegmental complex afferents to both segments of the globus pallidus. Non-specific regional cholinergic nerve terminal associations with rigidity scores likely reflect more complex multifactorial signalling mechanisms with smaller contributions from cholinergic pathways.
format Online
Article
Text
id pubmed-8196256
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-81962562021-12-11 Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson’s disease Bohnen, Nicolaas I Kanel, Prabesh Koeppe, Robert A Sanchez-Catasus, Carlos A Frey, Kirk A Scott, Peter Constantine, Gregory M Albin, Roger L Müller, Martijn L T M Brain Commun Original Article Clinical effects of anti-cholinergic drugs implicate cholinergic systems alterations in the pathophysiology of some cardinal motor impairments in Parkinson’s disease. The topography of affected cholinergic systems deficits and motor domain specificity are poorly understood. Parkinson's disease patients (n = 108) underwent clinical and motor assessment and vesicular acetylcholine transporter [(18)F]-fluoroethoxybenzovesamicol PET imaging. Volumes-of-interest-based analyses included detailed thalamic and cerebellar parcellations. Successful PET sampling for most of the small-sized parcellations was available in 88 patients. A data-driven approach, stepwise regression using the forward selection method, was used to identify cholinergic brain regions associating with cardinal domain-specific motor ratings. Regressions with motor domain scores for model-selected regions followed by confounder analysis for effects of age of onset, duration of motor disease and levodopa equivalent dose were performed. Among 7 model-derived regions associating with postural instability and gait difficulties domain scores three retained significance in confounder variable analysis: medial geniculate nucleus (standardized β = −0.34, t = −3.78, P = 0.0003), lateral geniculate nucleus (β = −0.32, t = −3.4, P = 0.001) and entorhinal cortex (β = −0.23, t = −2.6, P = 0.011). A sub-analysis of non-episodic postural instability and gait difficulties scores demonstrated significant effects of the medial geniculate nucleus, entorhinal cortex and globus pallidus pars interna. Among 6 tremor domain model-selected regions two regions retained significance in confounder variable analysis: cerebellar vermis section of lobule VIIIb (β = −0.22, t = −2.4, P = 0.021) and the putamen (β = −0.23, t = −2.3, P = 0.024). None of the three model-selected variables for the rigidity domain survived confounder analysis. Two out of the four model-selected regions for the distal limb bradykinesia domain survived confounder analysis: globus pallidus pars externa (β = 0.36, t = 3.9, P = 0.0097) and the paracentral lobule (β = 0.26, t = 2.5, P = 0.013). Emphasizing the utility of a systems-network conception of the pathophysiology of Parkinson's disease cardinal motor features, our results are consistent with specific deficits in basal forebrain corticopetal, peduncupontine-laterodorsal tegmental complex, and medial vestibular nucleus cholinergic pathways, against the background of nigrostriatal dopaminergic deficits, contributing significantly to postural instability, gait difficulties, tremor and distal limb bradykinesia cardinal motor features of Parkinson’s disease. Our results suggest significant and distinct consequences of degeneration of cholinergic peduncupontine-laterodorsal tegmental complex afferents to both segments of the globus pallidus. Non-specific regional cholinergic nerve terminal associations with rigidity scores likely reflect more complex multifactorial signalling mechanisms with smaller contributions from cholinergic pathways. Oxford University Press 2021-05-22 /pmc/articles/PMC8196256/ /pubmed/34704022 http://dx.doi.org/10.1093/braincomms/fcab109 Text en Published by Oxford University Press on behalf of the Guarantors of Brain 2021. This work is written by US Government employees and is in the public domain in the US. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by/4.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Article
Bohnen, Nicolaas I
Kanel, Prabesh
Koeppe, Robert A
Sanchez-Catasus, Carlos A
Frey, Kirk A
Scott, Peter
Constantine, Gregory M
Albin, Roger L
Müller, Martijn L T M
Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson’s disease
title Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson’s disease
title_full Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson’s disease
title_fullStr Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson’s disease
title_full_unstemmed Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson’s disease
title_short Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson’s disease
title_sort regional cerebral cholinergic nerve terminal integrity and cardinal motor features in parkinson’s disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196256/
https://www.ncbi.nlm.nih.gov/pubmed/34704022
http://dx.doi.org/10.1093/braincomms/fcab109
work_keys_str_mv AT bohnennicolaasi regionalcerebralcholinergicnerveterminalintegrityandcardinalmotorfeaturesinparkinsonsdisease
AT kanelprabesh regionalcerebralcholinergicnerveterminalintegrityandcardinalmotorfeaturesinparkinsonsdisease
AT koepperoberta regionalcerebralcholinergicnerveterminalintegrityandcardinalmotorfeaturesinparkinsonsdisease
AT sanchezcatasuscarlosa regionalcerebralcholinergicnerveterminalintegrityandcardinalmotorfeaturesinparkinsonsdisease
AT freykirka regionalcerebralcholinergicnerveterminalintegrityandcardinalmotorfeaturesinparkinsonsdisease
AT scottpeter regionalcerebralcholinergicnerveterminalintegrityandcardinalmotorfeaturesinparkinsonsdisease
AT constantinegregorym regionalcerebralcholinergicnerveterminalintegrityandcardinalmotorfeaturesinparkinsonsdisease
AT albinrogerl regionalcerebralcholinergicnerveterminalintegrityandcardinalmotorfeaturesinparkinsonsdisease
AT mullermartijnltm regionalcerebralcholinergicnerveterminalintegrityandcardinalmotorfeaturesinparkinsonsdisease